Forkhead box Q1: A key player in the pathogenesis of tumors (Review)
- Authors:
- Yang Li
- Yefei Zhang
- Zhendong Yao
- Sisi Li
- Zhenhua Yin
- Min Xu
-
Affiliations: Department of Gastroenterology, Shanghai General Hospital of Nanjing Medical University, Shanghai 200080, P.R. China, Department of Gastroenterology, Shanghai General Hospital of Shanghai Jiaotong University, Hongkou, Shanghai 200080, P.R. China - Published online on: May 12, 2016 https://doi.org/10.3892/ijo.2016.3517
- Pages: 51-58
This article is mentioned in:
Abstract
 |
 |
 |
|
Weigel D, Jürgens G, Küttner F, Seifert E and Jäckle H: The homeotic gene fork head encodes a nuclear protein and is expressed in the terminal regions of the Drosophila embryo. Cell. 57:645–658. 1989. View Article : Google Scholar : PubMed/NCBI | |
|
Kaestner KH, Knochel W and Martinez DE: Unified nomenclature for the winged helix/forkhead transcription factors. Genes Dev. 14:142–146. 2000.PubMed/NCBI | |
|
Overdier DG, Porcella A and Costa RH: The DNA-binding specificity of the hepatocyte nuclear factor 3/forkhead domain is influenced by amino-acid residues adjacent to the recognition helix. Mol Cell Biol. 14:2755–2766. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Lai E, Prezioso VR, Smith E, Litvin O, Costa RH and Darnell JE Jr: HNF-3A, a hepatocyte-enriched transcription factor of novel structure is regulated transcriptionally. Genes Dev. 4:1427–1436. 1990. View Article : Google Scholar : PubMed/NCBI | |
|
Lai E, Prezioso VR, Tao WF, Chen WS and Darnell JE Jr: Hepatocyte nuclear factor 3 alpha belongs to a gene family in mammals that is homologous to the Drosophila homeotic gene fork head. Genes Dev. 5:416–427. 1991. View Article : Google Scholar : PubMed/NCBI | |
|
Benayoun BA, Caburet S and Veitia RA: Forkhead transcription factors: Key players in health and disease. Trends Genet. 27:224–232. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Carlsson P and Mahlapuu M: Forkhead transcription factors: Key players in development and metabolism. Dev Biol. 250:1–23. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Lin L, Miller CT, Contreras JI, Prescott MS, Dagenais SL, Wu R, Yee J, Orringer MB, Misek DE, Hanash SM, et al: The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas. Cancer Res. 62:5273–5279. 2002.PubMed/NCBI | |
|
Li J and Vogt PK: The retroviral oncogene qin belongs to the transcription factor family that includes the homeotic gene fork head. Proc Natl Acad Sci USA. 90:4490–4494. 1993. View Article : Google Scholar : PubMed/NCBI | |
|
Koo CY, Muir KW and Lam EW: FOXM1: From cancer initiation to progression and treatment. Biochim Biophys Acta. 1819:28–37. 2012. View Article : Google Scholar | |
|
Nakamura T, Furukawa Y, Nakagawa H, Tsunoda T, Ohigashi H, Murata K, Ishikawa O, Ohgaki K, Kashimura N, Miyamoto M, et al: Genome-wide cDNA microarray analysis of gene expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissection. Oncogene. 23:2385–2400. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Myatt SS and Lam EW: The emerging roles of forkhead box (Fox) proteins in cancer. Nat Rev Cancer. 7:847–859. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Cao D, Hustinx SR, Sui G, Bala P, Sato N, Martin S, Maitra A, Murphy KM, Cameron JL, Yeo CJ, et al: Identification of novel highly expressed genes in pancreatic ductal adenocarcinomas through a bioinformatics analysis of expressed sequence tags. Cancer Biol Ther. 3:1081–1089; discussion 1090-1091. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Tang H, Guo Q, Zhang C, Zhu J, Yang H, Zou YL, Yan Y, Hong D, Sou T and Yan XM: Identification of an intermediate signature that marks the initial phases of the colorectal adenoma-carcinoma transition. Int J Mol Med. 26:631–641. 2010.PubMed/NCBI | |
|
Feuerborn A, Srivastava PK, Küffer S, Grandy WA, Sijmonsma TP, Gretz N, Brors B and Gröne HJ: The Forkhead factor FoxQ1 influences epithelial differentiation. J Cell Physiol. 226:710–719. 2011. View Article : Google Scholar | |
|
Katoh M and Katoh M: Human FOX gene family (Review). Int J Oncol. 25:1495–1500. 2004.PubMed/NCBI | |
|
Abba M, Patil N, Rasheed K, Nelson LD, Mudduluru G, Leupold JH and Allgayer H: Unraveling the role of FOXQ1 in colorectal cancer metastasis. Mol Cancer Res. 11:1017–1028. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Bieller A, Pasche B, Frank S, Gläser B, Kunz J, Witt K and Zoll B: Isolation and characterization of the human forkhead gene FOXQ1. DNA Cell Biol. 20:555–561. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Hannenhalli S and Kaestner KH: The evolution of Fox genes and their role in development and disease. Nat Rev Genet. 10:233–240. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Hoggatt AM, Kriegel AM, Smith AF and Herring BP: Hepatocyte nuclear factor-3 homologue 1 (HFH-1) represses transcription of smooth muscle-specific genes. J Biol Chem. 275:31162–31170. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Jonsson H and Peng SL: Forkhead transcription factors in immunology. Cell Mol Life Sci. 62:397–409. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Hong H-K, Noveroske JK, Headon DJ, Liu T, Sy MS, Justice MJ and Chakravarti A: The winged helix/forkhead transcription factor Foxq1 regulates differentiation of hair in satin mice. Genesis. 29:163–171. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Potter CS, Peterson RL, Barth JL, Pruett ND, Jacobs DF, Kern MJ, Argraves WS, Sundberg JP and Awgulewitsch A: Evidence that the satin hair mutant gene Foxq1 is among multiple and functionally diverse regulatory targets for Hoxc13 during hair follicle differentiation. J Biol Chem. 281:29245–29255. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Wu B, Herbert Pratt C, Potter CS, Silva KA, Kennedy V and Sundberg JP: R164C mutation in FOXQ1 H3 domain affects formation of the hair medulla. Exp Dermatol. 22:234–236. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Calin GA and Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Garzon R, Fabbri M, Cimmino A, Calin GA and Croce CM: MicroRNA expression and function in cancer. Trends Mol Med. 12:580–587. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Narasimhan K, Gauthaman K, Pushparaj PN, Meenakumari G, Chaudhary AGA, Abuzenadah A, Gari MA, Al Qahtani M and Manikandan J: Identification of unique miRNA biomarkers in colorectal adenoma and carcinoma using microarray: evaluation of their putative role in disease progression. ISRN Cell Biol. 2014.1–10. 2014. View Article : Google Scholar | |
|
Valencia-Sanchez MA, Liu J, Hannon GJ and Parker R: Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev. 20:515–524. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Shimono Y, Zabala M, Cho RW, Lobo N, Dalerba P, Qian D, Diehn M, Liu H, Panula SP, Chiao E, et al: Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell. 138:592–603. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Chen J, Chen Y and Chen Z: MiR-125a/b regulates the activation of cancer stem cells in paclitaxel-resistant colon cancer. Cancer Invest. 31:17–23. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Li L, Li Z, Kong X, Xie D, Jia Z, Jiang W, Cui J, Du Y, Wei D, Huang S, et al: Down-regulation of microRNA-494 via loss of SMAD4 increases FOXM1 and β-catenin signaling in pancreatic ductal adenocarcinoma cells. Gastroenterology. 147:485–497.e18. 2014. View Article : Google Scholar | |
|
Peng XH, Huang HR, Lu J, Liu X, Zhao FP, Zhang B, Lin SX, Wang L, Chen HH, Xu X, et al: MiR-124 suppresses tumor growth and metastasis by targeting Foxq1 in nasopharyngeal carcinoma. Mol Cancer. 13:186–198. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang J, Yang Y, Yang T, Yuan S, Wang R, Pan Z, Yang Y, Huang G, Gu F, Jiang B, et al: Double-negative feedback loop between microRNA-422a and forkhead box (FOX)G1/Q1/E1 regulates hepatocellular carcinoma tumor growth and metastasis. Hepatology. 61:561–573. 2015. View Article : Google Scholar | |
|
Zhang Z, Ma J, Luan G, Kang L, Su Y, He Y and Luan F: MiR-506 suppresses tumor proliferation and invasion by targeting FOXQ1 in nasopharyngeal carcinoma. PLoS One. 10:e01228512015. View Article : Google Scholar : PubMed/NCBI | |
|
Xiang XJ, Deng J, Liu YW, Wan LY, Feng M, Chen J and Xiong JP: MiR-1271 inhibits cell proliferation, invasion and EMT in gastric cancer by targeting FOXQ1. Cell Physiol Biochem. 36:1382–1394. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Ford SA and Blanck G: Signal persistence and amplification in cancer development and possible, related opportunities for novel therapies. Biochim Biophys Acta. 1855:18–23. 2015. | |
|
Nusse R and Varmus HE: Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell. 31:99–109. 1982. View Article : Google Scholar : PubMed/NCBI | |
|
Ochoa-Hernández AB, Juárez-Vázquez CI, Rosales-Reynoso MA and Barros-Núñez P: WNT-β-catenin signaling pathway and its relationship with cancer. Cir Cir. 80:389–398. 2012.(In Spanish). | |
|
Christensen J, Bentz S, Sengstag T, Shastri VP and Anderle P: FOXQ1, a novel target of the Wnt pathway and a new marker for activation of Wnt signaling in solid tumors. PLoS One. 8:e600512013. View Article : Google Scholar : PubMed/NCBI | |
|
Fan DM, Feng XS, Qi PW and Chen YW: Forkhead factor FOXQ1 promotes TGF-β1 expression and induces epithelial-mesenchymal transition. Mol Cell Biochem. 397:179–186. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Katsuno Y, Lamouille S and Derynck R: TGF-β signaling and epithelial-mesenchymal transition in cancer progression. Curr Opin Oncol. 25:76–84. 2013. View Article : Google Scholar | |
|
Peng X, Luo Z, Kang Q, Deng D, Wang Q, Peng H, Wang S and Wei Z: FOXQ1 mediates the crosstalk between TGF-β and Wnt signaling pathways in the progression of colorectal cancer. Cancer Biol Ther. 16:1099–1109. 2015. View Article : Google Scholar : | |
|
Yap KL, Sysa-Shah P, Bolon B, Wu RC, Gao M, Herlinger AL, Wang F, Faiola F, Huso D, Gabrielson K, et al: Loss of NAC1 expression is associated with defective bony patterning in the murine vertebral axis. PLoS One. 8:e690992013. View Article : Google Scholar : PubMed/NCBI | |
|
Mackler S, Pacchioni A, Degnan R, Homan Y, Conti AC, Kalivas P and Blendy JA: Requirement for the POZ/BTB protein NAC1 in acute but not chronic psychomotor stimulant response. Behav Brain Res. 187:48–55. 2008. View Article : Google Scholar | |
|
Shih Ie M, Nakayama K, Wu G, Nakayama N, Zhang J and Wang TL: Amplification of the ch19p13.2 NACC1 locus in ovarian high-grade serous carcinoma. Mod Pathol. 24:638–645. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Nakayama K, Nakayama N, Wang TL and Shih IeM: NAC-1 controls cell growth and survival by repressing transcription of Gadd45GIP1, a candidate tumor suppressor. Cancer Res. 67:8058–8064. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Gao M, Shih IeM and Wang TL: The role of forkhead box Q1 transcription factor in ovarian epithelial carcinomas. Int J Mol Sci. 13:13881–13893. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Hanahan D and Weinberg RA: Hallmarks of cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Bicknell KA: Forkhead (FOX) transcription factors and the cell cycle: Measurement of DNA binding by FoxO and FoxM transcription factors. Methods Mol Biol. 296:247–262. 2005. | |
|
Wonsey DR and Follettie MT: Loss of the forkhead transcription factor FoxM1 causes centrosome amplification and mitotic catastrophe. Cancer Res. 65:5181–5189. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Meng F, Speyer CL, Zhang B, Zhao Y, Chen W, Gorski DH, Miller FR and Wu G: PDGFRα and β play critical roles in mediating Foxq1-driven breast cancer stemness and chemoresistance. Cancer Res. 75:584–593. 2015. View Article : Google Scholar | |
|
Ushkaryov YA, Petrenko AG, Geppert M and Südhof TC: Neurexins: Synaptic cell surface proteins related to the alpha-latrotoxin receptor and laminin. Science. 257:50–56. 1992. View Article : Google Scholar : PubMed/NCBI | |
|
Rowen L, Young J, Birditt B, Kaur A, Madan A, Philipps DL, Qin S, Minx P, Wilson RK, Hood L, et al: Analysis of the human neurexin genes: Alternative splicing and the generation of protein diversity. Genomics. 79:587–597. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Tabuchi K and Südhof TC: Structure and evolution of neurexin genes: Insight into the mechanism of alternative splicing. Genomics. 79:849–859. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Kusinska R, Górniak P, Pastorczak A, Fendler W, Potemski P, Mlynarski W and Kordek R: Influence of genomic variation in FTO at 16q12.2, MC4R at 18q22 and NRXN3 at 14q31 genes on breast cancer risk. Mol Biol Rep. 39:2915–2919. 2012. View Article : Google Scholar : | |
|
Sun HT, Cheng SX, Tu Y, Li XH and Zhang S: FoxQ1 promotes glioma cells proliferation and migration by regulating NRXN3 expression. PLoS One. 8:e556932013. View Article : Google Scholar : PubMed/NCBI | |
|
Harper JW, Adami GR, Wei N, Keyomarsi K and Elledge SJ: The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 75:805–816. 1993. View Article : Google Scholar : PubMed/NCBI | |
|
Dworakowska D, Jassem E, Jassem J, Boltze C, Wiedorn KH, Dworakowski R, Skokowski J, Jaśkiewicz K and Czestochowska E: Absence of prognostic significance of p21(WAF1/CIP1) protein expression in non-small cell lung cancer. Acta Oncol. 44:75–79. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Abbas T and Dutta A: p21 in cancer: Intricate networks and multiple activities. Nat Rev Cancer. 9:400–414. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Kaneda H, Arao T, Tanaka K, Tamura D, Aomatsu K, Kudo K, Sakai K, De Velasco MA, Matsumoto K, Fujita Y, et al: FOXQ1 is overexpressed in colorectal cancer and enhances tumorigenicity and tumor growth. Cancer Res. 70:2053–2063. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Folkman J: Tumor angiogenesis: Therapeutic implications. N Engl J Med. 285:1182–1186. 1971. View Article : Google Scholar : PubMed/NCBI | |
|
Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1:27–31. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Volpert OV, Dameron KM and Bouck N: Sequential development of an angiogenic phenotype by human fibroblasts progressing to tumorigenicity. Oncogene. 14:1495–1502. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Ellis LM and Hicklin DJ: VEGF-targeted therapy: Mechanisms of anti-tumour activity. Nat Rev Cancer. 8:579–591. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Klein CA: Parallel progression of primary tumours and metastases. Nat Rev Cancer. 9:302–312. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Williams SA, Anderson WC, Santaguida MT and Dylla SJ: Patient-derived xenografts, the cancer stem cell paradigm, and cancer pathobiology in the 21st century. Lab Invest. 93:970–982. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Timpl R, Rohde H, Robey PG, Rennard SI, Foidart JM and Martin GR: Laminin - a glycoprotein from basement membranes. J Biol Chem. 254:9933–9937. 1979.PubMed/NCBI | |
|
Colognato H and Yurchenco PD: Form and function: The laminin family of heterotrimers. Dev Dyn. 218:213–234. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Ross JB, Huh D, Noble LB and Tavazoie SF: Identification of molecular determinants of primary and metastatic tumour re-initiation in breast cancer. Nat Cell Biol. 17:651–664. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Baeriswyl V and Christofori G: The angiogenic switch in carcinogenesis. Semin Cancer Biol. 19:329–337. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Bergers G and Benjamin LE: Tumorigenesis and the angiogenic switch. Nat Rev Cancer. 3:401–410. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Stauffer JK, Scarzello AJ, Jiang Q and Wiltrout RH: Chronic inflammation, immune escape, and oncogenesis in the liver: A unique neighborhood for novel intersections. Hepatology. 56:1567–1574. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Qian BZ and Pollard JW: Macrophage diversity enhances tumor progression and metastasis. Cell. 141:39–51. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Xia L, Huang W, Tian D, Zhang L, Qi X, Chen Z, Shang X, Nie Y and Wu K: Forkhead box Q1 promotes hepatocellular carcinoma metastasis by transactivating ZEB2 and Versican V1 expression. Hepatology. 59:958–973. 2014. View Article : Google Scholar | |
|
Larue L and Bellacosa A: Epithelial-mesenchymal transition in development and cancer: Role of phosphatidylinositol 3′ kinase/AKT pathways. Oncogene. 24:7443–7454. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Barouki R and Coumoul X: Cell migration and metastasis markers as targets of environmental pollutants and the Aryl hydrocarbon receptor. Cell Adhes Migr. 4:72–76. 2010. View Article : Google Scholar | |
|
Dietrich C and Kaina B: The aryl hydrocarbon receptor (AhR) in the regulation of cell-cell contact and tumor growth. Carcinogenesis. 31:1319–1328. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Feng J, Zhang X, Zhu H, Wang X, Ni S and Huang J: FoxQ1 overexpression influences poor prognosis in non-small cell lung cancer, associates with the phenomenon of EMT. PLoS One. 7:e399372012. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu Z, Zhu Z, Pang Z, Xing Y, Wan F, Lan D and Wang H: Short hairpin RNA targeting FOXQ1 inhibits invasion and metastasis via the reversal of epithelial-mesenchymal transition in bladder cancer. Int J Oncol. 42:1271–1278. 2013.PubMed/NCBI | |
|
Gao M, Wu RC, Herlinger AL, Yap K, Kim JW, Wang TL and Shih IeM: Identification of the NAC1-regulated genes in ovarian cancer. Am J Pathol. 184:133–140. 2014. View Article : Google Scholar : | |
|
Sehrawat A, Kim SH, Vogt A and Singh SV: Suppression of FOXQ1 in benzyl isothiocyanate-mediated inhibition of epithelial-mesenchymal transition in human breast cancer cells. Carcinogenesis. 34:864–873. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang H, Meng F, Liu G, Zhang B, Zhu J, Wu F, Ethier SP, Miller F and Wu G: Forkhead transcription factor foxq1 promotes epithelial-mesenchymal transition and breast cancer metastasis. Cancer Res. 71:1292–1301. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Chambers AF, Groom AC and MacDonald IC: Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer. 2:563–572. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Steeg PS: Tumor metastasis: Mechanistic insights and clinical challenges. Nat Med. 12:895–904. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Mengual L, Ars E, Lozano JJ, Burset M, Izquierdo L, Ingelmo-Torres M, Gaya JM, Algaba F, Villavicencio H, Ribal MJ, et al: Gene expression profiles in prostate cancer: Identification of candidate non-invasive diagnostic markers. Actas Urol Esp. 38:143–149. 2014. View Article : Google Scholar | |
|
Pei Y, Wang P, Liu H, He F and Ming L: FOXQ1 promotes esophageal cancer proliferation and metastasis by negatively modulating CDH1. Biomed Pharmacother. 74:89–94. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Huang W, Chen Z, Shang X, Tian D, Wang D, Wu K, Fan D and Xia L: Sox12, a direct target of FoxQ1, promotes hepatocellular carcinoma metastasis through up-regulating Twist1 and FGFBP1. Hepatology. 61:1920–1933. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Sánchez-Tilló E, Siles L, de Barrios O, Cuatrecasas M, Vaquero EC, Castells A and Postigo A: Expanding roles of ZEB factors in tumorigenesis and tumor progression. Am J Cancer Res. 1:897–912. 2011.PubMed/NCBI | |
|
Xiong H, Hong J, Du W, Lin YW, Ren LL, Wang YC, Su WY, Wang JL, Cui Y, Wang ZH, et al: Roles of STAT3 and ZEB1 proteins in E-cadherin down-regulation and human colorectal cancer epithelial-mesenchymal transition. J Biol Chem. 287:5819–5832. 2012. View Article : Google Scholar : | |
|
Cong N, Du P, Zhang A, Shen F, Su J, Pu P, Wang T, Zjang J, Kang C and Zhang Q: Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma. Oncol Rep. 29:1579–1587. 2013.PubMed/NCBI | |
|
Kiefer JC: Back to basics: Sox genes. Dev Dyn. 236:2356–2366. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Kamachi Y and Kondoh H: Sox proteins: Regulators of cell fate specification and differentiation. Development. 140:4129–4144. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Hoser M, Potzner MR, Koch JM, Bösl MR, Wegner M and Sock E: Sox12 deletion in the mouse reveals nonreciprocal redundancy with the related Sox4 and Sox11 transcription factors. Mol Cell Biol. 28:4675–4687. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Jung HY and Yang J: Unraveling the TWIST between EMT and cancer stemness. Cell Stem Cell. 16:1–2. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Tassi E, Al-Attar A, Aigner A, Swift MR, McDonnell K, Karavanov A and Wellstein A: Enhancement of fibroblast growth factor (FGF) activity by an FGF-binding protein. J Biol Chem. 276:40247–40253. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Tassi E, McDonnell K, Gibby KA, Tilan JU, Kim SE, Kodack DP, Schmidt MO, Sharif GM, Wilcox CS, Welch WJ, et al: Impact of fibroblast growth factor-binding protein-1 expression on angiogenesis and wound healing. Am J Pathol. 179:2220–2232. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Qin J, Xu Y, Li X, Wu Y, Zhou J, Wang G and Chen L: Effects of lentiviral-mediated Foxp1 and Foxq1 RNAi on the hepatocarcinoma cell. Exp Mol Pathol. 96:1–8. 2014. View Article : Google Scholar | |
|
Palchaudhuri R and Hergenrother PJ: Transcript profiling and RNA interference as tools to identify small molecule mechanisms and therapeutic potential. ACS Chem Biol. 6:21–33. 2011. View Article : Google Scholar : | |
|
Uprichard SL: The therapeutic potential of RNA interference. FEBS Lett. 579:5996–6007. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Bao B, Azmi AS, Aboukameel A, Ahmad A, Bolling-Fischer A, Sethi S, Ali S, Li Y, Kong D, Banerjee S, et al: Pancreatic cancer stem-like cells display aggressive behavior mediated via activation of FoxQ1. J Biol Chem. 289:14520–14533. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Wattenberg LW: Inhibition of carcinogenic effects of polycyclic hydrocarbons by benzyl isothiocyanate and related compounds. J Natl Cancer Inst. 58:395–398. 1977.PubMed/NCBI |
